Truist 3Q26 net income falls 45% year over year to $799 million
Bitget2026/10/16 10:26- Truist’s third-quarter 2026 diluted EPS fell 46% year over year to $0.56.
- Revenue dropped 28% year over year to $3.75 billion; securities losses totaled $1.45 billion.
- Credit losses swung to a $253 million benefit from a provision a year earlier, driven by the RAC loan sale’s reserve release.
- An October 14 agreement calls for selling $7.7 billion of unsecured consumer loans, representing substantially all LightStream assets, to Carlyle Group.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Tom Lee Says Yields Below 5% Mean the AI Selloff Is Nearly Over
Allergy and autoimmune biotechnology company Lycia Therapeutics (LYCA.US) will be listed on Nasdaq tonight! IPO priced at $18 per share, aiming to raise $317.5 millions.
Lycia will issue 17.64 million shares at a price of $18 per share to raise $317.5 million.
Citi is bullish on Palantir (PLTR.US): U.S. government and commercial businesses jointly drive growth, Q3 revenue is expected to exceed expectations again
Citigroup maintains its "Buy" rating on Palantir and raises the target price from $245 to $250.
Despite its stock price being halved, Goldman Sachs maintains a Buy rating: Holding $10 billions in orders, CoreWeave (CRWV) faces a major test with several billions in financing
As a core manufacturer of AI computing power infrastructure, CoreWeave (CRWV.US) holds orders worth tens of billions and its business is expanding rapidly. However, capital expenditure pressure and financing gaps have become the main concerns of the market.
Crypto prices
More
